Your browser is no longer supported. Please, upgrade your browser.
UTHR United Therapeutics Corporation daily Stock Chart
UTHR [NASD]
United Therapeutics Corporation
Index- P/E- EPS (ttm)-2.45 Insider Own0.10% Shs Outstand44.22M Perf Week1.55%
Market Cap4.10B Forward P/E9.24 EPS next Y10.04 Insider Trans-17.36% Shs Float43.11M Perf Month-8.38%
Income-104.50M PEG- EPS next Q2.72 Inst Own96.50% Short Float7.34% Perf Quarter7.26%
Sales1.45B P/S2.83 EPS this Y-117.90% Inst Trans0.01% Short Ratio5.09 Perf Half Y18.43%
Book/sh63.48 P/B1.46 EPS next Y-4.62% ROA-2.70% Target Price132.44 Perf Year-21.73%
Cash/sh33.60 P/C2.76 EPS next 5Y-11.38% ROE-4.00% 52W Range74.31 - 121.11 Perf YTD5.29%
Dividend- P/FCF- EPS past 5Y-18.90% ROI-3.60% 52W High-23.42% Beta0.84
Dividend %- Quick Ratio3.80 Sales past 5Y2.40% Gross Margin91.90% 52W Low24.80% ATR5.89
Employees920 Current Ratio4.00 Sales Q/Q-18.40% Oper. Margin-13.10% RSI (14)49.87 Volatility5.17% 7.03%
OptionableNo Debt/Eq0.31 EPS Q/Q-16.80% Profit Margin-7.20% Rel Volume1.15 Prev Close93.53
ShortableYes LT Debt/Eq0.22 EarningsFeb 26 BMO Payout- Avg Volume622.26K Price92.74
Recom2.20 SMA203.42% SMA50-4.00% SMA2006.08% Volume718,176 Change-0.84%
Mar-10-20Upgrade Jefferies Hold → Buy $123
Feb-27-20Upgrade Cowen Market Perform → Outperform $119 → $145
Jan-31-20Upgrade JP Morgan Neutral → Overweight $120
Dec-03-19Initiated BofA/Merrill Underperform
Aug-01-19Upgrade Ladenburg Thalmann Neutral → Buy $103 → $106
Aug-01-19Upgrade Jefferies Underperform → Hold $90
Jul-01-19Upgrade Credit Suisse Neutral → Outperform $98 → $101
May-17-19Upgrade UBS Sell → Neutral $115 → $94
May-09-19Upgrade Credit Suisse Underperform → Neutral $98
Oct-12-18Upgrade Standpoint Research Hold → Buy
Aug-08-18Downgrade Credit Suisse Neutral → Underperform
Apr-03-18Upgrade Credit Suisse Underperform → Neutral
Feb-22-18Reiterated Barclays Underweight $115 → $105
Jan-18-18Resumed Credit Suisse Underperform $118
Dec-27-17Reiterated Wedbush Outperform $213 → $232
Apr-27-17Reiterated Wedbush Outperform $229 → $213
Mar-30-17Initiated UBS Sell $112
Mar-16-17Initiated Credit Suisse Underperform
Mar-06-17Downgrade Jefferies Hold → Underperform
Feb-23-17Downgrade Ladenburg Thalmann Buy → Neutral
Apr-01-20 05:50PM  United Therapeutics (UTHR) Stock Moves -0.98%: What You Should Know Zacks
Mar-27-20 02:53PM  Hedge Funds Have Never Been This Bullish On United Therapeutics Corporation (UTHR) Insider Monkey
11:30AM  United Therapeutics (UTHR) Down 8.7% Since Last Earnings Report: Can It Rebound? Zacks
Mar-26-20 02:53PM  The Top 10 Biotechnology Companies Investopedia
Mar-16-20 11:30AM  Is United Therapeutics (UTHR) Outperforming Other Medical Stocks This Year? Zacks -13.58%
Mar-15-20 11:28PM  Edited Transcript of UTHR earnings conference call or presentation 26-Feb-20 2:00pm GMT Thomson Reuters StreetEvents
Feb-28-20 11:30AM  Is United Therapeutics (UTHR) Stock Outpacing Its Medical Peers This Year? Zacks
06:43AM  Zacks.com featured highlights include: McKesson, United Therapeutics, Virtusa and Cardinal Health Zacks
Feb-27-20 10:44AM  United Therapeutics (UTHR) Down on Q4 Earnings & Sales Miss Zacks
10:40AM  Arena Pharmaceuticals (ARNA) Q4 Earnings Miss, Revenues Top Zacks
09:41AM  4 Finest Value Stocks Based on Discounted PEG Zacks
Feb-26-20 09:03AM  Jazz Pharma (JAZZ) Surpasses Q4 Earnings & Sales Estimates Zacks -6.25%
07:30AM  United Therapeutics (UTHR) Lags Q4 Earnings and Revenue Estimates Zacks
Feb-25-20 08:17AM  Will United Therapeutics Continue to Surge Higher? Zacks
06:00AM  United Therapeutics Corporation To Present At The 40th Annual Cowen And Company Healthcare Conference PR Newswire
Feb-24-20 01:56PM  United Therapeutics gets good news and stock boost from drug candidate American City Business Journals +7.84%
06:16AM  United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin® PR Newswire
06:00AM  United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints PR Newswire
Feb-21-20 02:25PM  Corcept (CORT) Q4 Earnings In-Line with Estimates, Up Y/Y Zacks
Feb-19-20 12:31PM  Earnings Preview: United Therapeutics (UTHR) Q4 Earnings Expected to Decline Zacks
11:13AM  Zacks.com featured highlights include: Tempur Sealy International, Twin River Worldwide, Rite Aid, DaVita and United Therapeutics Zacks
06:00AM  United Therapeutics Corporation to Report Fourth Quarter and Full Year 2019 Financial Results Before the Market Opens on Wednesday, February 26, 2020 PR Newswire
Feb-18-20 09:51AM  5 Stocks in Focus on Remarkable Relative Price Strength Zacks
Feb-14-20 10:36AM  New Strong Buy Stocks for February 14th Zacks
Feb-05-20 03:01PM  Court sides with United Therapeutics in suit from generic competitor, but doesn't dismiss case American City Business Journals
02:39PM  5 Stocks Trading Below Peter Lynch Value GuruFocus.com
11:15AM  Biotech Stock Roundup: Earnings Updates From VRTX, AMGN, GILD; AIMT Gains FDA Nod Zacks
07:43AM  The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data Benzinga
Feb-04-20 12:10PM  Why United Therapeutics (UTHR) is Poised to Beat Earnings Estimates Again Zacks
Feb-03-20 08:42AM  United Therapeutics gets disappointing news on cancer therapy American City Business Journals
06:00AM  United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint PR Newswire
Jan-17-20 08:16AM  Arena's (ARNA) Heart Failure Candidate Gets Fast Track Status Zacks
Jan-06-20 06:00AM  United Therapeutics Corporation To Present At The 38th Annual J.P. Morgan Healthcare Conference PR Newswire
Jan-03-20 09:01AM  Arena (ARNA) Expands Strategic Deal With Beacon Discovery Zacks
Dec-27-19 03:40PM  Hedge Fund Favorites vs. United Therapeutics Corporation (UTHR) In 2019 Insider Monkey
Dec-17-19 02:07PM  Are Investors Undervaluing United Therapeutics Corporation (NASDAQ:UTHR) By 41%? Simply Wall St.
Dec-06-19 03:07PM  Brandes Investments' Top 5 Buys in the 3rd Quarter GuruFocus.com
Dec-03-19 04:44PM  United Therapeutics (UTHR): Hedge Funds Were Patiently Waiting For Strong Gains Insider Monkey
02:43PM  Bank Of America Initiates United Therapeutics With Bearing Rating, Cites Unclear Growth Outlook Benzinga
Nov-14-19 07:00AM  Correvio Reports Third Quarter 2019 Financial Results CNW Group
Nov-08-19 08:56AM  Arena Pharmaceuticals' (ARNA) Q3 Loss Widens, Revenues Beat Zacks
Nov-04-19 11:38AM  Edited Transcript of UTHR earnings conference call or presentation 30-Oct-19 1:00pm GMT Thomson Reuters StreetEvents
Oct-31-19 11:45AM  United Therapeutics (UTHR) Q3 Earnings & Sales Top, Stock Up Zacks
06:50AM  Will United Therapeutics Continue to Surge Higher? Zacks
Oct-30-19 10:54AM  Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial Zacks
07:30AM  United Therapeutics (UTHR) Tops Q3 Earnings and Revenue Estimates Zacks
06:00AM  United Therapeutics Corporation Reports Third Quarter 2019 Financial Results PR Newswire
Oct-29-19 10:40AM  Exelixis (EXEL) to Report Q3 Earnings: What's in the Cards? Zacks
10:10AM  Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report? Zacks
08:44AM  5 Solid Relative Price Strength Stocks to Make You Rich Zacks
Oct-25-19 11:28AM  United Therapeutics Corporation (UTHR): Hedge Funds Had A Change of Heart Insider Monkey
Oct-23-19 10:33AM  Analysts Estimate United Therapeutics (UTHR) to Report a Decline in Earnings: What to Look Out for Zacks
06:00AM  United Therapeutics Corporation to Report Third Quarter 2019 Financial Results Before the Market Opens on Wednesday, October 30, 2019 PR Newswire
Oct-21-19 06:00AM  United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study PR Newswire
Oct-18-19 11:12AM  Does United Therapeutics Corporation (NASDAQ:UTHR) Have A Volatile Share Price? Simply Wall St.
Oct-14-19 09:15AM  Zoetis (ZTS) Soars to 52-Week High, Time to Cash Out? Zacks
Oct-02-19 05:00AM  Some local CEOs are paid much more than their employees here's how much American City Business Journals
Sep-18-19 05:58AM  Investors Who Bought United Therapeutics (NASDAQ:UTHR) Shares Five Years Ago Are Now Down 38% Simply Wall St.
Sep-12-19 11:25AM  United Therapeutics' Trevyent NDA for PAH Accepted by FDA Zacks
07:00AM  Correvio Highlights FDA Acceptance of United Therapeutics' Trevyent New Drug Application CNW Group
Sep-11-19 06:00AM  United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review PR Newswire
Aug-23-19 12:00PM  MNKD: Q2 2019: Record Revenue, Margins as Rx Continue to Ramp. Clinical Evidence Driving Adoption Zacks Small Cap Research
Aug-19-19 04:35PM  iBio Inks 3D Bioprinting Agreement GlobeNewswire
Aug-16-19 09:24AM  Is United Therapeutics Corporation's (NASDAQ:UTHR) CEO Paid Enough Relative To Peers? Simply Wall St.
Aug-14-19 07:00AM  Correvio Reports Second Quarter 2019 Financial Results CNW Group
Aug-10-19 08:32AM  Edited Transcript of UTHR earnings conference call or presentation 31-Jul-19 1:00pm GMT Thomson Reuters StreetEvents
Aug-09-19 09:25AM  Zoetis (ZTS) Hits Fresh High: Is There Still Room to Run? Zacks
Aug-08-19 11:23AM  MannKind Corporation (MNKD) Q2 2019 Earnings Call Transcript Motley Fool
10:34AM  Arena Pharmaceuticals' (ARNA) Q2 Loss Widens, Revenues Meet Zacks
Aug-06-19 06:00AM  United Therapeutics Corporation To Present At 2019 Wedbush PacGrow Healthcare Conference PR Newswire
Aug-01-19 09:49AM  United Therapeutics (UTHR) Q2 Earnings & Sales Beat, Down Y/Y Zacks
Jul-31-19 11:01PM  United Therapeutics Corporation (UTHR) 2019 Q2 Earnings Call Transcript Motley Fool
02:44PM  United Therapeutics is executing its growth plan. Why isnt its stock price higher? American City Business Journals
07:30AM  United Therapeutics (UTHR) Q2 Earnings and Revenues Beat Estimates Zacks
06:00AM  United Therapeutics Corporation Reports Second Quarter 2019 Financial Results PR Newswire
Jul-24-19 06:00AM  United Therapeutics Corporation To Report Second Quarter 2019 Financial Results Before The Market Opens On Wednesday, July 31, 2019 PR Newswire
Jul-17-19 01:00PM  What You Should Know About United Therapeutics Corporation's (NASDAQ:UTHR) Financial Strength Simply Wall St.
Jul-11-19 12:25AM  Sexual harassment lawsuit against Md. biotech to advance with plaintiff's identity revealed American City Business Journals
Jul-03-19 09:15AM  S&P Makes It Two Record Closes in a Row Zacks
Jul-01-19 02:37PM  Credit Suisse: United Therapeutics Becoming More Fundamentally Driven Benzinga +5.11%
09:28AM  United Therapeutics Stock Jumps After Analyst Says Its Slide Was Overdone Barrons.com
Jun-26-19 09:15AM  Stocks Slide as Fed Dampens Rate Cut Expectations Zacks
Jun-18-19 10:38AM  Arena Initiates Dosing in Pivotal Colitis Study on Etrasimod Zacks
Jun-17-19 02:59PM  Have Insiders Been Selling United Therapeutics Corporation (NASDAQ:UTHR) Shares? Simply Wall St.
Jun-13-19 11:19AM  Heres What Hedge Funds Think About United Therapeutics Corporation (UTHR) Insider Monkey
Jun-10-19 01:01PM  Impact on Jacksonville of mega-merger of United Technologies and Raytheon is uncertain American City Business Journals
Jun-05-19 06:00AM  United Therapeutics Corporation to Present at Goldman Sachs 40th Annual Global Healthcare Conference PR Newswire
May-28-19 06:00AM  United Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference PR Newswire
May-23-19 11:42AM  The Catalyst: Creating Innovation in Health Care - United Therapeutics' Martine Rothblatt at Healthy Returns CNBC Videos
May-09-19 09:03AM  Arena Pharmaceuticals' (ARNA) Loss Widens in Q1 But Stock Up Zacks
May-08-19 03:50PM  Before You Buy United Therapeutics Corporation (NASDAQ:UTHR), Consider Its Volatility Simply Wall St.
09:24AM  MannKind Corporation (MNKD) Q1 2019 Earnings Call Transcript Motley Fool
May-07-19 03:27PM  Edited Transcript of UTHR earnings conference call or presentation 1-May-19 1:00pm GMT Thomson Reuters StreetEvents
06:00AM  United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin® PR Newswire
May-02-19 05:25PM  United Therapeutics zeroes in on new business lines in wake of generic competition American City Business Journals
09:26AM  United Therapeutics (UTHR) Down Despite Q1 Earnings Beat Zacks
May-01-19 01:16PM  United Therapeutics (UTHR) Beats Q1 Earnings and Revenue Estimates Zacks
12:45PM  United Therapeutics Corporation (UTHR) Q1 2019 Earnings Call Transcript Motley Fool
06:16AM  United Therapeutics: 1Q Earnings Snapshot Associated Press
06:00AM  United Therapeutics Corporation Reports First Quarter 2019 Financial Results PR Newswire
United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening diseases primarily in the United States and internationally. The company's commercial therapies include Remodulin, an infused formulation of the prostacyclin analogue treprostinil for subcutaneous and intravenous administration to diminish symptoms associated with exercise in pulmonary arterial hypertension (PAH) patients; Tyvaso, an inhaled formulation of treprostinil to enhace the exercise ability in PAH patients; Orenitram, a tablet dosage form of treprostinil to enhance the exercise capacity in PAH patients; Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients; and Unituxin, a monoclonal antibody for treating neuroblastoma. It also engages in developing OreniPro, RemoPro, Treprostinil Technosphere, Trevyent, Ralinepag, and Aurora-GT to treat PAH; LNG01 to treat IPF; Unexisome to treat BPD and the research and development of various organ transplantation-related technologies, including regenerative medicine, xenotransplantation, biomechanical lungs, and ex-vivo lung perfusion, as well as the development of medicine for other diseases. The company has licensing and collaboration agreements with Medtronic, Inc. to develop and commercialize the implantable system for Remodulin; Caremark, L.L.C. to provide refills of implanted pumps at its infusion centers; DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of Remodulin; MannKind Corporation to develop and license treprostinil inhalation powder, and Dreamboat and Cricket devices; Arena Pharmaceuticals, Inc. to develop ralinepag for the treatment of PAH; and Samumed LLC to develop SM04646, a phase I development-stage Wnt pathway inhibitor for treating idiopathic pulmonary fibrosis. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Giltner RichardDirectorMar 26Option Exercise51.775,000258,8508,750Mar 27 04:34 PM
Giltner RichardDirectorMar 26Sale91.755,000458,7503,750Mar 27 04:34 PM
SULLIVAN LOUIS WDirectorMar 25Option Exercise48.1115,000721,65022,120Mar 27 04:33 PM
SULLIVAN LOUIS WDirectorMar 23Option Exercise54.776,000328,62013,120Mar 24 04:32 PM
PATUSKY CHRISTOPHERDirectorMar 17Option Exercise54.775,000273,8505,000Mar 18 04:30 PM
Thompson Tommy GDirectorMar 02Option Exercise51.778,500440,04530,440Mar 03 04:02 PM
Thompson Tommy GDirectorMar 02Sale103.594,290444,40926,150Mar 03 04:02 PM
Mesa NildaDirectorOct 31Option Exercise0.002,66002,660Jan 16 04:06 PM
DWEK RAYMONDDirectorJun 27Sale76.113,750285,4130Jun 28 04:25 PM
DWEK RAYMONDDirectorJun 26Option Exercise0.003,75003,750Jun 28 04:25 PM
Thompson Tommy GDirectorJun 26Option Exercise0.001,870021,940Jun 28 04:24 PM
KURZWEIL RAYDirectorJun 26Option Exercise0.001,87005,240Jun 28 04:18 PM
Olian Judy D.DirectorJun 26Option Exercise0.001,87008,000Jun 28 04:20 PM
Giltner RichardDirectorJun 26Option Exercise0.003,75003,750Jun 28 04:15 PM
SULLIVAN LOUIS WDirectorJun 26Option Exercise0.003,75005,120Jun 28 04:13 PM
Giltner RichardDirectorJun 20Option Exercise41.145,000205,7005,000Jun 21 09:03 AM
Giltner RichardDirectorJun 20Sale79.055,000395,2500Jun 21 09:03 AM
Giltner RichardDirectorJun 13Option Exercise41.145,000205,7005,000Jun 13 04:04 PM
Giltner RichardDirectorJun 06Option Exercise41.145,000205,7005,000Jun 06 04:01 PM
Giltner RichardDirectorMay 30Option Exercise41.145,000205,7005,000May 31 04:07 PM
Giltner RichardDirectorApr 05Option Exercise41.145,000205,7005,000Apr 05 04:10 PM
CAUSEY CHRISTOPHERDirectorApr 04Option Exercise63.9075047,9251,725Apr 05 04:11 PM